Elancourt, France

Bernard Portevin


 

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 239(Granted Patents)


Location History:

  • Elancourt, FR (1991 - 2008)
  • Fay aux Loges, FR (2011)

Company Filing History:


Years Active: 1991-2011

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Bernard Portevin: Innovator in Pharmaceutical Patents

Introduction

Bernard Portevin, an accomplished inventor based in Elancourt, France, has made significant contributions to the field of pharmaceuticals, specifically in the area of angiotensin-converting enzyme inhibitors and serotonin reuptake inhibitors. With a portfolio of 20 patents, Portevin's innovations have paved the way for advancements in medical treatments.

Latest Patents

Among his recent patents is the invention of addition salts of angiotensin-converting enzyme inhibitors with no donor acids, along with a process for their preparation and pharmaceutical compositions containing them. This innovation relates to compounds designated by the formula (I): (A)·(B) where A represents an angiotensin-converting enzyme inhibitor containing at least one salt-forming basic function, and B signifies a compound with at least one salt-forming acid function and at least one NO donor group. This groundbreaking patent aims to provide medicinal products that are beneficial in treating cardiovascular pathologies. Additionally, Portevin has developed indanyl-piperazine compounds that are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK-antagonist.

Career Highlights

Throughout his career, Bernard has been associated with renowned companies such as Adir Et Compagnie and Les Laboratoires Servier, where he has been instrumental in advancing pharmaceutical research and development. His work has not only strengthened these companies but has also contributed significantly to the overall industry.

Collaborations

Portevin has collaborated with notable professionals, including Guillaume De Nanteuil and Georges Remond. Their joint efforts have fostered an environment of innovation and have led to fruitful advancements in medicinal chemistry.

Conclusion

Bernard Portevin's dedication to innovation and excellence in the pharmaceutical domain is demonstrated by his numerous patents and impactful collaborations. His work continues to inspire future generations of inventors and researchers in the quest for improved medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…